Chinese Medical E-ournals Database

Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition) ›› 2019, Vol. 15 ›› Issue (06): 646 -654. doi: 10.3877/cma.j.issn.1673-5250.2019.06.007

Special Issue:

Original Article

Analysis of different risk values of Down syndrome or 18 trisomy syndrome in the first trimester screening and fetal chromosomal abnormalities and pregnancy outcomes of pregnant women

Hong Wang1, Chun Duan1, Hui Yuan2, Xiaoxia Wu2, Jiansheng Xie2,(), Guanglin Zhao3   

  1. 1. Department of Clinical Laboratory, Shenzhen Maternity & Child Healthcare Hospital Affiliated to Southern Medical University, Shenzhen 518028, Guangdong Province, China
    2. Prenatal Diagnosis Center, Shenzhen Maternity & Child Healthcare Hospital Affiliated to Southern Medical University, Shenzhen 518028, Guangdong Province, China
    3. Department of Information, Shenzhen Maternity & Child Healthcare Hospital Affiliated to Southern Medical University, Shenzhen 518028, Guangdong Province, China
  • Received:2019-06-13 Revised:2019-11-12 Published:2019-12-01
  • Corresponding author: Jiansheng Xie
  • About author:
    Corresponding author: Xie Jiansheng, Email:
  • Supported by:
    National Natural Science Foundation of China(31471204)
Objective

To explore high risk, intermediate risk and low risk values of Down syndrome (DS) or 18 trisomy syndrome in first trimester screening in pregnant women and their fetal chromosomal abnormalities and pregnancy outcomes.

Methods

From January to December 2017, a total of 14 598 singleton pregnant women who received first trimester screening in Shenzhen Maternity & Child Healthcare Hospital Affiliated to Southern Medical University and with pregnancy outcomes were selected as research subjects. Their pregnancy outcomes were followed-up by searching information from Prenatal Diagnosis Center of our hospital or Shenzhen Maternal and Child Health Information Management System or telephoning the research subjects. Follow-up of pregnancy outcomes for live births was conducted from 1-12 months after birth or the occurrence of spontaneous abortion/stillbirth or termination of pregnancy. Among them, 6 825 cases received first trimester serological screening only, and 7 773 cases received first trimester serological screening combined with fetal ultrasound nuchal translucency (NT) detection. And 1 082 cases were with high risk of fetal DS or 18 trisomy syndrome in first trimester screening, 1 903 cases were with intermediate risk, and 11 613 cases were with low risk. There were 2 223 cases of pregnant women with advanced age (≥35-year old at parturition), accounting for 15.23% (2 223/14 598). Retrospective research method was used to collect first trimester screening results, fetal chromosomal abnormalities and pregnancy outcomes of all pregnant women. Chi-square test was used to compare screening positive rate (SPR) of fetal DS and 18 trisomy syndrome in pregnant women of different ages (<35-year old and ≥35-year old at parturition), rate of fetal chromosomal abnormalities and incidence of adverse pregnancy outcomes in pregnant women with high risk, intermediate risk and low risk of fetal DS or 18 trisomy syndrome in first trimester screening. The procedures in this study were in line with the requirements of World Medical Association Declaration of Helsinki revised in 2013.

Results

①The SPR of fetal DS and 18 trisomy syndrome of first trimester pregnant women with advanced maternal age were 22.22% (494/2 223) and 1.30% (29/2 223), respectively, which were statistically higher than those 4.00% (495/12 375) and 0.52% (649/12 375) of pregnant women <35-year old, and both the differences were statistically significant (χ2=990.737, 18.456; P<0.001). ②There were 51 cases of fetal chromosomal abnormalities among 14 598 cases of pregnant women, 49 cases were prenatally diagnosed and 2 cases were postnatally diagnosed by neonate peripheral blood karyotype analysis, and the rate of fetal chromosomal abnormalities was 0.35% (51/14 598). Among the 51 cases of fetal chromosomal abnormalities, 26 cases were DS, and 22 case of them were high-risk of DS in first trimester screening, and 4 cases were intermediate and low risk of DS in first trimester screening, the DS detection rate was 84.62% (22/26), the rate of fetal DS was 0.18% (26/14 598); and 3 cases were 18 trisomy syndrome, all of them were high risk of 18 trisomy syndrome in first trimester screening, the detection rate of 18 trisomy syndrome was 100.00% (3/3); and 15 cases were sex chromosome abnormalities, the rate of sex chromosome abnormalities was 0.10% (15/14 598); 2 cases were 13 trisomy syndrome and 5 cases were structural chromosome abnormalities. ③Among pregnant women with high risk, intermediate risk, and low risk of fetal DS or 18 trisomy syndrome in first trimester screening, 31 cases, 7 cases and 13 cases of fetuses respectively were diagnosed as fetal chromosomal abnormalities, and rate of fetal chromosomal abnormalities of them were 2.87% (31/1 082), 0.37% (7/1 903), and 0.11% (13/11 613), respectively. Among pregnant women with intermediate risk and low risk of fetal DS or 18 trisomy syndrome in first trimester screening, 20 cases were diagnosed as fetal chromosomal abnormalities, 19 cases were prenatally diagnosed, including 17 cases with abnormal results in noninvasive prenatal test (NIPT), 1 cases of advanced age and 1 case of NT thickening; and 1 case was postnatally diagnosed. ④Excluding 51 cases of pregnant women with fetal chromosomal abnormalities, among another 14 547 cases of pregnant women with different risks of first trimester screening, the incidences of adverse pregnancy outcomes including termination of pregnancy due to fetal ultrasound abnormality, spontaneous abortion/stillbirth, premature delivery and birth defects of pregnant women with high risk, intermediate risk and low risk of first trimester screening were 9.32% (98/1 051), 5.17% (98/1 896) and 4.19% (486/11 600), respectively, and the difference was statistically significant (χ2=57.989, P<0.001).

Conclusions

The detection rates of fetal DS and 18 trisomy syndrome are high in first trimester screening, but not all fetal chromosomal abnormalities can be detected out. In pregnant women with intermediate risk and low risk of fetal DS or 18 trisomy syndrome in first trimester screening, fetal chromosomal abnormalities still may be found among them, and further NIPT can be helpful to detect fetal chromosomal abnormal in those pregnant women. In pregnant women with high risk of fetal DS or 18 trisomy syndrome in first trimester screening, except for high rate of fetal chromosomal abnormalities, the incidences of other adverse pregnancy outcomes, such as termination of pregnancy due to fetal ultrasound abnormality, spontaneous abortion/stillbirth, premature birth, and birth defects are also relatively high.

表1 不同年龄孕妇的胎儿DS和18-三体综合征SPR比较[例数(%)]
表2 14 598例孕妇早孕期筛查结果为DS或18-三体综合征不同风险值的胎儿染色体异常情况
表3 20例孕妇早孕期筛查结果为DS或18-三体综合征临界风险和低风险的胎儿染色体异常情况
孕妇编号(No.) 年龄(岁) 孕龄(周) DS风险值 18-三体综合征 NT厚度(mm) 血清PAPP-A MoM 血清fβ-HCG MoM 产前诊断指征(NIPT结果) 胎儿染色体核型异常情况 妊娠结局
1 31 12+2 1/353 低风险 2.2 0.70 1.11 DS高风险 47,XN+21 终止妊娠
2 42 12+6 1/508 低风险 1.4 0.82 1.45 高龄 47,XXY 终止妊娠
3 28 13+0 1/577 低风险 1.8 2.48 5.38 45,X[4]/46,XY[56] 活产
4 38 12+5 1/583 低风险 1.5 0.69 1.89 性染色体数目增多 47,XXX 终止妊娠
5 34 12+0 1/625 低风险 1.7 0.34 0.58 DS高风险 47,XN+21 终止妊娠
6 41 12+1 1/777 低风险 1.3 0.74 1.08 性染色体数目增多 47,XXY 终止妊娠
7 44 12+1 1/898 低风险 1.40 0.48 性染色体数目增多 47,XXY 终止妊娠
8 28 12+5 1/1 032 低风险 0.37 0.80 性染色体数目减少 45,XO 终止妊娠
9 24 12+1 1/1 152 低风险 0.63 1.51 DS高风险 47,XN+21 终止妊娠
10 30 13+2 1/1 172 低风险 2.0 0.58 1.46 DS高风险 47,XN+21 终止妊娠
11 34 12+5 1/1 818 低风险 1.4 0.64 1.66 性染色体数目增多 47,XXY 终止妊娠
12 28 10+0 1/1 907 低风险 1.16 0.65 性染色体数目增多 47,XXX 活产
13 34 12+6 1/2 095 低风险 0.45 0.42 NT厚度为5.6 mm 47,XN+13 终止妊娠
14 27 11+1 1/2 357 低风险 0.51 0.74 性染色体数目增多 47,XXX 终止妊娠
15 37 13+4 1/3 193 低风险 0.43 1.44 性染色体数目增多 47,XXY 终止妊娠
16 37 11+5 1/8 502 低风险 0.28 0.96 性染色体数目增多 47,XXX 活产
17 31 11+1 1/14 499 低风险 1.03 0.67 性染色体数目增多 47,XXY 终止妊娠
18 31 12+0 1/30 382 低风险 1.2 0.69 0.42 18号染色体微缺失 染色体结构异常 终止妊娠
19 33 11+2 1/14 809 低风险 1.2 0.46 0.42 性染色体数目增多 47,XXY 终止妊娠
20 29 13+5 1/21 157 低风险 0.6 0.63 1.40 性染色体减少 染色体微重复、微缺失 终止妊娠
表4 14 547例孕妇(排除51例胎儿染色体异常孕妇)早孕期筛查结果为DS或18-三体综合征不同风险值的不良妊娠结局比较
[1]
Nicolaides KH, Azar G, Byrne D, et al. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy[J]. BMJ, 1992, 304(6831): 867-869.
[2]
Snijders RJ, Noble P, Sebire N, et al. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group[J]. Lancet, 1998, 352(9125): 343-346.
[3]
Schaelike M, Kossakiewicz M, Kossakiewicz A, et al. Examination of a first-trimester Down syndrome screening concept on a mix of 11, 107 high-and low-risk patients at a private center for prenatal medicine in Germany[J]. Eur J Obstet Gynecol Reprod Biol, 2009, 144(2): 140-145.
[4]
Morgan S, Delbarre A, Ward P. Impact of introducing a national policy for prenatal Down syndrome screening on the diagnostic invasive procedure rate in England[J]. Ultrasound Obstet Gynecol, 2013, 41(5): 526-529.
[5]
谢幸,孔北华,段涛. 妇产科学[M]. 9版. 北京:人民卫生出版社,2018: 64-65.
[6]
Santorum M, Wright D, Syngelaki A, et al. Accuracy of first-trimester combined test in screening for trisomies 21, 18 and 13[J]. Ultrasound Obstet Gynecol, 2017, 49(6): 714-720.
[7]
许遵鹏,李蓓,廖灿,等. 广州市早孕期产前筛查胎儿染色体异常的结果分析[J]. 中华医学遗传学杂志,2014, 31(5): 632-635.
[8]
何天文,陈柯艺,唐斌,等. 20 323例孕早期一站式唐氏筛查结果分析[J]. 国际检验医学杂志,2016, 37(1): 35-36, 39.
[9]
葛婷婷,孙庆梅,吴菊,等. 12 807例孕早期唐氏筛查的临床应用现状分析[J]. 中国优生与遗传杂志,2018, 26(6): 54-55.
[10]
何法霖,赵彦,王薇,等. 2014年早孕期母血清产前筛查检验项目室内质控结果调查与分析[J]. 中国妇幼保健杂志,2015, 30(8): 1235-1236.
[11]
郑文吉,陈志央,余颀,等. 早孕期唐氏综合征筛查指标中位数本地化的研究[J]. 中华围产医学杂志,2016, 19(10): 785-788.
[12]
涂新枝,段纯,李玉哲,等. 无创胎儿DNA检测在2 949例传统唐氏筛查临界风险孕妇中的应用[J]. 天津医药杂志,2017, 5(2): 180-183.
[13]
孔京慧,李娴,赵鼎,等. 郑州地区628例先天畸形新生儿的细胞遗传学分析[J]. 中华医学遗传学杂志,2018, 35(6): 926-927.
[14]
宋春林,郭晓玲,陈淑芬,等. 无创产前检测在胎儿性染色体检测中的应用价值[J]. 中国优生与遗传杂志,2018, 26(5): 36-37.
[15]
罗艳梅,胡华梅,徐聚春,等. 无创产前基因检测在胎儿染色体非整倍体筛查中的应用研究[J]. 实用妇产科杂志,2018, 34(6): 464-467.
[16]
Kornman L, Palma-Dias R, Nisbet D, et al. Non-invasive prenatal testing for sex chromosome aneuploidy in routine clinical practice[J]. Fetal Diagn Ther, 2018, 44(2): 85-90.
[17]
Gregg AR, Skotko BG, Benkendorf JL, et al. Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics[J]. Genet Med, 2016, 18(10): 1056-1065.?
[18]
苏杭,刘之英,赖怡,等. 高龄孕妇产前诊断结果及其首选无创产前筛查局限性的大样本分析[J/CD]. 中华妇幼临床医学杂志(电子版), 2018, 14(6): 719-723.
[19]
侯亚萍,杨洁霞,郭芳芳,等. 无创DNA产前检测在胎儿染色体非整倍体疾病筛查中的应用[J]. 检验医学与临床,2018, 15(11): 1542-1544, 1548.
[20]
张敏,梅瑾,张闻,等. 唐氏综合征产前筛查高风险与不良妊娠结局的相关性探讨[J]. 现代实用医学,2016, 28(9): 1206-1208.
[21]
潘敏,孙茜,陈儒香,等. 唐氏综合征产前筛查结果为极高风险孕妇的妊娠结局分析[J/CD]. 中华妇幼临床医学杂志(电子版), 2019, 15(2): 157-163.
[1] Fei Dai, Bowen Zhao, Mei Pan, Xiaohui Peng, Ran Chen, Yuanshi Tian, Ming Di. Value of multiple fetal echocardiographic quantitative parameters in assessing heart structure and function in fetuses with coarctation of the aorta[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(10): 950-958.
[2] Zusheng Du, Bowen Zhao, Zhen Zhang, Mei Pan, Xiaohui Peng, Ran Chen, Yankai Mao. Impact of gestational age and apex orientation on left atrial strain assessed by two-dimensional speckle tracking imaging in normal fetuses during the second and third trimesters[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(09): 843-851.
[3] Shangdi Zhang, Bowen Zhao, Mei Pan, Xiaohui Peng, Ran Chen, Yankai Mao, Yang Chen, Hua Yuan, Yan Chen. Value of quantitative fetal atrial size parameters in assessing cardiac malformations in fetuses with atrial disproportion in middle and late trimesters[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(08): 785-793.
[4] Qiulian Wang, Ying Zhang, Chunmin Li, Shuming Xu, Yuqi Zhang. Prenatal ultrasound diagnosis of fetal aortic arch obstruction with complex intracardiac structural malformations: causes of missed diangosis and misdiagnosis[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(07): 718-725.
[5] Lili Gu, Fan Jiang. Survey and analysis of quality of screening prenatal ultrasound images in Anhui Province[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(07): 671-674.
[6] Qing Zeng, Huaxuan Wen, Ying Yuan, Yimei Liao, Yue Qin, Dandan Luo, Meiling Liang, Shengli Li. Sylvian fissure plateau angle: a new parameter to evaluate fetal sylvian fissure by transabdominal two-dimensional ultrasound[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(05): 454-459.
[7] Gang Luo, Silin Pan, Lingyu Sun, Zhixin Li, Taotao Chen, Sibo Qiao, Shanchen Pang. Classification of right ventricular hypoplasia in fetuses diagnosed with pulmonary atresia with an intact ventricular septum or critical pulmonary stenosis via a new semantic parsing network model[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2024, 21(04): 377-383.
[8] Jingyu Qian, Mingming Zheng. Interpretation of the Italian guidelines on non-invasive and invasive prenatal diagnosis:executive summary of recommendations for practice the Italian Society for Obstetrics and Gynecology(SIGO)[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 486-492.
[9] Xialin Li, Fang He. Risk assessment and early warning system for postpartum hemorrhage[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 498-503.
[10] Ziyang Liu, Jianjian Cui, Yin Zhao. Current research status on obstetric disseminated intravascular coagulation and its scoring system[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 511-518.
[11] Fanying Zeng, Jie Ruan, Xinghui Liu, Guolin He. Current status of perinatal medicine advances under the new reproductive situation and coping strategies in prenatal care[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 519-524.
[12] Xiaofei Li, Hongli Liu, Qiuling Shi, Jing Tian, Li Li, Hongbo Qi, Xin Luo. A prospective randomized controlled study of low intensity focused ultrasound uterine involution treatment for prevention and treatment of postpartum hemorrhage in natural childbirth women[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 534-539.
[13] Rong Huang, Ziyu Liang, Wenjin Qi. Expression and significance of NLRP3 inflammasome in serum of pregnant women with premature rupture of membranes[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 540-548.
[14] Xia He, Rong Huang, Wenjin Qi. High-throughput sequencing study on the abundance of placenta and fetal membrane flora in pregnant women with premature rupture of membranes[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 549-555.
[15] Jiangyan Xie, Yafei Wang, Fang He. Pregnancy complicated with thrombotic thrombocytopenic purpura:two cases report and literature review[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(05): 556-563.
Viewed
Full text


Abstract